Do you want to read an article? Please log in or register.
Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer
Gastrointestinal Cancer
Related content
Gastrointestinal Cancer
Quantitative spatial profiling of PD-1/PD-L1 and TIGIT/CD155 interaction indicates poor survival outcome and resistance to adjuvant chemotherapy in pancreatic adenosquamous carcinoma
Eur J Cancer
Chen X, Sun S, Li S, Yu S, Chen J, Chen X, Shi X, Liang Z
doi: 10.1016/j.ejca.2025.116159
Gastrointestinal Cancer
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
N Engl J Med
O'Reilly EM, Wainberg ZA, Hendifar AE, Borad MJ, Pietrantonio F, Pant S, Hammel P, Cremolini C, Manji GA, Oberstein PE, Garrido-Laguna I, Springfeld C, Azad NS, Ueno M, Chui SY, Zhang Y, Patel H, Lee Y, Salman Z, Wolpin BM, RASolute 302 Trial Investigators
doi: 10.1056/NEJMoa2605555
Pancreas Diseases
GSK3β(high)/NFATc1(high) subtype targeting overcomes therapy resistance in pancreatic cancer through transcriptional induction of homologous recombination repair
Gut
Latif MU, Liu X, Bockelmann A, Huhnold L, Schmidt GE, Klein L, Zhao X, Conradi LC, Conrads K, Weber AL, Mercan S, Reutlinger K, Paul A, Najafova Z, Johnsen SA, Bonilla Del Rio Z, Penz F, Todorovic J, Bastians H, Beissbarth T, Sax U, Ashry R, Krämer OH, Hessmann E, Schneider G, Stroebel P, Bogeski I, Singh SK, Ellenrieder V
doi: 10.1136/gutjnl-2025-336227
RECOMMENDED
Gastrointestinal Cancer
Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
N Engl J Med
Park W, Kasi A, Spira AI, Paz-Ares Rodríguez L, Herzberg BO, Pelster MS, Tolcher AW, Kuboki Y, Kitano S, Shoji H, Wang JS, Berlin JD, Hollebecque A, LoRusso P, Fountzilas C, Cassier PA, Nishina T, Sakai D, Inagaki C, Morgensztern D, Ueno M, Jung M, Kim SW, Jänne PA, Italiano A, You B, Macarulla T, Fujii H, Shetty A, Lu Y, Cui D, Kadam S, Gill SC, Toyoshima J, Saito T, Goldman JW
doi: 10.1056/NEJMoa2600752
Gastrointestinal Cancer
Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study
Lancet
Shen L, Zhang X, Ji K, Lu L, Wang Q, Guan Q, Yan S, Zhou Y, Yang Y, Huo Z, You J, Ba Y, Ye Y, Chen Y, Wang S, Lv G, Zhang J, Hu X, Yang F, Yu H, Li J, Wang Q, Zhu J, Ji J, ASTRUM-006 Study Group
doi: 10.1016/S0140-6736(26)00974-8
Gastrointestinal Cancer
Trends in Pancreatic Cancer Incidence, Mortality and Net Survival: A Population-Based Analysis in Zurich (Switzerland), 1981-2021
J Gastrointest Cancer
Vinci L, Wanner M, Wicki A, Moch H, Korol D, Rohrmann S
doi: 10.1007/s12029-026-01498-8
Gastrointestinal Cancer
Increased risk of young-onset pancreatic cancer among adults aged 20-39 years with overweight or obesity, but not underweight: A nationwide cohort study
Eur J Cancer
Kim HJ, Park JH, Hong JY, Han K, Shen JJ, Park JO, Park YS, Lim HY
doi: 10.1016/j.ejca.2025.116111
Gastrointestinal Cancer
Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis
Eur J Cancer
Bregni G, Leurquin B, Giasafaki P, Takemura N, Kokudo N, Hasegawa K, Matsuyama Y, Nishioka Y, Aparicio T, Guimbaud R, Malicot KL, Tu D, O'Callaghan C, Lutz MP, Fontana E, Moehler M, Mauer ME, Sclafani F
doi: 10.1016/j.ejca.2025.116092
Gastrointestinal Cancer
Risk of pancreatic cancer associated with precursor lesions in individuals and first-degree relatives: a nationwide cohort study
Clin Gastroenterol Hepatol
Ludvigsson JF, Sun J, Yuan C, Vujasinovic M, Löhr JM, Wolpin BM, Wang QL
doi: 10.1016/j.cgh.2026.06.009